Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
We have researched and compiled a list ... FDA-approved weight loss supplement that can help block about 25 percent of the fat you eat from being absorbed, alli Diet Weight Loss Supplement Pills ...
News wrap: Key events that happened this week include, approval of resolution for statehood restoration in Jammu and Kashmir, BJP and NCP (SP) first list of candidates for Maharashtra Assembly ...
Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...
In the complaint, the attorneys general argue that expanding access to abortion pills poses a potential injury to their states because it leads to lower birth rates, including among teenagers.
Oct 25 (Reuters) - The U.S. Food and Drug Administration has approved Iterum ... 2024 Healthcare & Pharmaceuticalscategory US FDA approves Johnson & Johnson's device for heart condition November ...
Back in April, the FDA approved Utility Therapeutics’ Pivya (pivmecillinam). The penicillin antibiotic underpinning Utility’s drug had never before been cleared in the U.S., despite being ...
(RTTNews) - Iterum Therapeutics plc (ITRM) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Iterum's new drug application for Orlynvah (sulopenem etzadroxil and ...
(Iterum), today announced that the U.S. Food and Drug Administration (FDA) has approved Iterum’s new drug application for ORLYNVAH™ (sulopenem etzadroxil and probenecid) for the treatment of ...